Physician profile
Sarah Morrison
NPI 1053832063
$6,104.15
in general payments reported to CMS, 2019-2025
27 companies · $1,083 in 2025
The $1,083 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,099 · 2020: $545 · 2021: $176 · 2022: $455 · 2023: $1,616 · 2024: $1,130 · 2025: $1,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,834 · Travel and Lodging: $943 · Consulting Fee: $52.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,833.78 |
| Travel and Lodging | $942.94 |
| Consulting Fee | $52.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,157.28 | 2019-2025 | Augment Injectable, Ortholoc 3di, Tissuemend |
| Arthrex, INC. | $1,034.96 | 2023 | |
| Liberty Surgical INC. | $758.00 | 2019 | |
| Smith+Nephew, INC. | $581.13 | 2021-2025 | Grafix Pl, Stravix, Oasis |
| Organogenesis INC. | $486.43 | 2022-2025 | Affinity, Puraply, Apligraf |
| Averitas Pharma INC. | $304.54 | 2023-2025 | Qutenza |
| Medical Device Business Services, INC. | $291.37 | 2019-2020 | |
| Treace Medical Concepts, INC. | $169.37 | 2025 | |
| Paladin Technology Solutions | $162.86 | 2022-2023 | |
| Stability Biologics, LLC | $160.38 | 2024-2025 | |
| Kci USA, INC. | $146.01 | 2019-2020 | |
| Integra Lifesciences Corporation | $117.65 | 2019 | |
| Next Science LLC | $107.18 | 2023-2024 | Blastx, Xperience, Surgx |
| Solventum Corporation | $105.78 | 2024 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Kerecis Limited | $100.12 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $92.50 | 2021-2025 | Nuzyra |
| Grt US Holding, INC. | $71.24 | 2022 | |
| Avita Medical Americas, LLC | $58.82 | 2024 | |
| Paragon 28, INC. | $32.40 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $29.78 | 2021-2022 | |
| Medtronic, INC. | $25.97 | 2023 | Intellis Adaptivestim |
| Orthofix Medical, INC. | $24.68 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.04 | 2025 | |
| Resmed Corp | $17.19 | 2023 | |
| Ibsa Pharma INC. | $17.07 | 2021 | |
| Urgo Medical North America, LLC | $16.98 | 2025 | Urgoclean Ag |
| Siemens Medical Solutions USA, INC. | $16.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.